Fox Jonathan C 4
4 · Edgewise Therapeutics, Inc. · Filed Jun 18, 2025
Insider Transaction Report
Form 4
Fox Jonathan C
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-06-16+30,000→ 30,000 totalExercise: $14.68From: 2026-06-16Exp: 2035-06-16→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]100% of the Stock Options granted on June 16, 2025 will become vested on the earlier of (i) June 16, 2026 or (ii) the business day prior to the 2026 annual meeting of stockholders.